Green Tea and EGCG
Green tea and green tea extract slightly lowered cholesterol, blood pressure and weight, mouth rinses reduced dental plaque; for cancer, no confirmed benefit was shown, and high-dose extracts can stress the liver.
We evaluated 265 human studies on Green Tea and EGCG, including 156 randomised controlled trials and 61 meta-analyses or systematic reviews; the controlled studies include 12,147 participants in total. As of 5 October 2026.
1. What Is Green Tea and EGCG? Occurrence, Origin and Forms
Green tea is an infusion of the leaves of the tea plant Camellia sinensis, which are barely oxidised after harvesting. EGCG (epigallocatechin gallate) is the most abundant catechin in green tea and belongs to the polyphenol group. Traditionally, green tea is drunk as an everyday beverage in East Asia; studies examine both the beverage and extracts made from it.
The leaves of Camellia sinensis provide the infusion; extracts are obtained from them and used in capsules, powders or beverages. The plant is cultivated mainly in East Asia and other subtropical regions.
For green tea, the leaf is briefly heated or steamed after harvesting and then dried, which largely prevents oxidation. For extracts, the leaves are leached with water or solvents and the result is dried; studies examine the infusion, the extract and individual catechins such as EGCG.
Forms and Preparations Studied
- Infusion of the leaves (beverage)
- Green tea extract in capsules or tablets
- Decaffeinated green tea or extract
- EGCG-enriched extract
- Ground leaf powder (for stirring in)
Not covered on this page:
- Black tea and oolong tea, in which the leaf is oxidised more strongly
- Herbal and fruit teas from other plant species
- Other catechins and polyphenols from sources other than Camellia sinensis
2. What Does Green Tea and EGCG Do? Results by Area
| Area | Result in controlled studies | Strength of evidence | Studies | Participants |
|---|---|---|---|---|
| Body weight and metabolism | mixed | high | 18 meta-analyses · 25 controlled · 13 other | 900 |
| Heart and circulation | mostly improved | high | 13 meta-analyses · 22 controlled · 12 other | 1,114 |
| Teeth and oral cavity | mostly improved | high | 2 meta-analyses · 18 controlled · 1 other | 716 |
| Skin | mixed | high | 1 meta-analyses · 5 controlled · 4 other | 239 |
| Cancer | mostly no difference | moderate | 2 meta-analyses · 5 controlled · 13 other | 1,371 |
| Liver | mostly no difference | moderate | 1 meta-analyses · 4 controlled · 5 other | 1,199 |
| Other investigations | mostly improved | high | 9 meta-analyses · 72 controlled · 38 other | 4,697 |
How to read the table: counted are human studies whose results concern the area. “High” means at least one meta-analysis and two controlled studies showing improvement, or at least three controlled studies of which three quarters show improvement, with at least 300 participants in total. “Moderate” means at least two controlled studies showing improvement, as a majority, or one meta-analysis alongside controlled studies. “Low” means one controlled study showing improvement. Where an area has no controlled study, the strength of evidence is at most “low” (result “reviews only” or “observational data only”). Everything else is “unclear”. A study counts as showing improvement when at least half of its outcomes in this area improved. Reviews of combination products do not count as meta-analyses; results that only describe side effects or shares of users do not count as an effect. The same study is counted only once.
3. What the Studies Show in Detail
Green Tea and EGCG, Body Weight and Metabolism: Human Studies
In overweight, according to meta-analyses, green tea extract slightly lowered body weight, BMI and body fat percentage 537. Drinks with added tea catechins reduced abdominal fat, including visceral fat, compared with placebo drinks 1385. In girls with obesity, a decaffeinated polyphenol extract lowered body fat percentage more than placebo 109. In addition to exercise, according to a meta-analysis, green tea brought only little additional weight loss 43. One meta-analysis found no weight difference outside Japan 59. Studies from Japan showed small advantages that the authors consider hardly clinically meaningful 59. A decaffeinated catechin extract did not change weight over one year 91. Meta-analyses found somewhat lower fasting blood sugar and HbA1c values with green tea, green tea extract and EGCG, but only a small effect for HbA1c 173845. Three cups of green tea daily lowered HbA1c and total cholesterol in type 2 diabetes with kidney damage compared with a group without tea 104. An overview of meta-analyses and a meta-analysis in metabolic syndrome, by contrast, found no difference 3047.
| Study | Design · participants | Preparation · dose · duration · comparison | Result |
|---|---|---|---|
| 1 Wang et al. 2025 | systematic review · 30,133 participants | Dietary supplements, including green tea catechins; vs. Placebo or control in 46 randomized trials | Adiposity: improved |
| 5 Asbaghi et al. 2024 | meta-analysis · 3,802 participants | green tea extract (GTE) as dietary supplement; vs. placebo or control | body mass (BM): improved (significantly reduced); body fat percentage (BFP): improved (significantly reduced); BMI: improved (significantly reduced) |
| 7 Ranneh et al. 2024 | systematic review · 1,840 participants | Polyphenol dietary supplementation, including green tea extract; vs. various polyphenol supplements versus control or each other | lipid profile: improved |
| 8 Jayedi et al. 2024 | meta-analysis · 1,710 participants | Green tea (beverage), compared with coffee, black tea, sour tea; average 10 weeks; vs. placebo, water, other beverages | weight loss versus placebo: improved (MD: −1·23 kg, 95 % CrI: −2·45, −0·02); weight loss versus water: improved (MD: −1·61 kg, 95 % CrI: −2·90, −0·35); weight loss versus water (healthy individuals): improved (MD: −3·31 kg, 95 % CrI: −5·83, −1·04) |
| 12 Zago et al. 2026 | meta-analysis · 1,109 participants | Green tea / green tea extract; vs. Placebo | Weight, BMI, body composition, blood glucose: no difference |
| 13 Hibi et al. 2018 | meta-analysis · 921 participants | Green tea catechin (GTC)-containing beverages; 540-588 mg GTC per beverage; 12 weeks; vs. Placebo beverage | Total fat area: improved (-17.7cm2, 95%CI: -20.9 to -14.4); Visceral fat area: improved (-7.5cm2, 95%CI: -9.3 to -5.7); Subcutaneous fat area: improved (-10.2cm2, 95%CI: -12.5 to -7.8) |
| 17 Jia et al. 2024 | meta-analysis · 722 participants | Green tea (form not specified); vs. Control group | Fasting blood glucose: improved (SMD = -0.41, 95% CI: -0.67 to -0.19, P = .001); Glycated hemoglobin: improved (SMD = -0.68, 95% CI: -1.15 to 0.21, P = .004); Insulin resistance index: improved (SMD = -0.70, 95% CI: -1.18 to -0.22, P = .005) |
| 18 Wang et al. 2023 | meta-analysis · 613 participants | green tea catechin supplement (extract); vs. control group (placebo) in 11 RCTs | waist circumference: improved (pooled WMD = -1.37 cm, 95 % CI: -2.52 to -0.22 cm, p = 0.019); triglyceride: improved (pooled WMD = -0.18 mmol/L, 95 % CI: -0.35 to -0.02 mmol/L, p = 0.032); HDL cholesterol: improved (pooled WMD = 0.07 mmol/L, 95 % CI: 0.01-0.14 mmol/L, p = 0.031) |
Further studies in this area: 21 23 30 37 38 39 43 45 46 47 53 57 59 63 78 85 91 104 109 115 120 126 132 137 140 142 151 155 156 157 158 159 160 167 171 174 175 184 189 205 211 213 215 222 223 224 231 232
Green Tea and EGCG, Heart and Circulation: Human Studies
Meta-analyses found somewhat lower total and LDL cholesterol with green tea and green tea catechins than in the control groups 6104557. Two types of green tea extract powder lowered LDL cholesterol more than placebo 78. For HDL cholesterol and triglycerides, the results were inconsistent 6101850. Meta-analyses also found a slight lowering of blood pressure by about one to two mmHg 92957. In overweight, metabolic syndrome and in a one-year extract study, by contrast, no difference was shown 183067. With green tea extract, HDL cholesterol fell in two studies, in one of them in addition to brisk walking 145184.
| Study | Design · participants | Preparation · dose · duration · comparison | Result |
|---|---|---|---|
| 2 Osadnik et al. 2022 | meta-analysis · 13,062 participants | Green tea extract compared with other nutraceuticals; vs. Placebo/no intervention and other nutraceuticals | LDL cholesterol: improved (-1.21 [-46.8 mg/dL] to -0.17 [-6.6 mg/dL] mmol/l reduction); Total cholesterol: improved (-1.75 [-67.7 mg/dL] to -0.18 [7 mg/dL] mmol/l reduction) |
| 3 Lagou et al. 2025 | meta-analysis · 5,205 participants | Flavan-3-ol-rich foods, beverages or supplements (incl. EGCG, tea, cocoa); 586 mg total flavan-3-ols (95% CI 510, 662); chronic repetitive consumption, duration not reported; vs. control (placebo/no intervention) | office blood pressure systolic/diastolic: improved (-2.8 [95% CI -3.9, -1.7]/-2.0 [-2.6, -1.3] mmHg); 24 h-ambulatory blood pressure systolic/diastolic: improved (-3.7 [-5.8, -1.6]/-2.6 [-4.5, -0.8] mmHg); flow-mediated dilation after acute consumption: improved (+2.0% [1.6, 2.3]) |
| 6 Xu et al. 2020 | meta-analysis · 3,321 participants | Green tea consumption (preparation form not specified); vs. Green tea supplementation versus control group | Total cholesterol: improved (WMD: - 4.66 mg/dL; 95% CI: - 6.36, - 2.96 mg/dL; P < 0.0001); LDL cholesterol: improved (WMD:- 4.55 mg/dL; 95% CI: - 6.31, - 2.80 mg/dL; P < 0.0001); HDL cholesterol: no difference |
| 9 Xu et al. 2020 | meta-analysis · 1,697 participants | Green tea supplementation (form not specified); short-term trials; vs. Placebo | Systolic blood pressure: improved (MD: -1.17 mm Hg; 95%CI: -2.18 to -0.16mm Hg; P = .02); Diastolic blood pressure: improved (MD: -1.24 mm Hg; 95%CI:-2.07 to -0.40mm Hg; P = .004) |
| 10 Kim et al. 2011 | meta-analysis · 1,415 participants | Green tea catechins (GTCs); 145 to 3,000 mg/day; 3 to 24 weeks; vs. Control | Total cholesterol: improved (-5.46 mg/dL [-0.14 mmol/L]; 95% CI -9.59 to -1.32); LDL cholesterol: improved (-5.30 mg/dL [-0.14 mmol/L]; 95% CI -9.99 to -0.62); HDL cholesterol: no difference (-0.27 mg/dL [-0.007 mmol/L]; 95% CI -1.62 to 1.09) |
| 12 Zago et al. 2026 | meta-analysis · 1,109 participants | Green tea / green tea extract; vs. Placebo | Total cholesterol: improved (MD: -7.03; 95% CI: -13.24 to -0.82; p = 0.03; I² = 0%); Lipid profile (other than total cholesterol): no difference |
| 13 Hibi et al. 2018 | meta-analysis · 921 participants | Green tea catechin (GTC)-containing beverages; 540-588 mg GTC per beverage; 12 weeks; vs. Placebo beverage | Blood pressure: improved |
| 18 Wang et al. 2023 | meta-analysis · 613 participants | green tea catechin supplement (extract); vs. control group (placebo) in 11 RCTs | blood pressure: no difference |
Further studies in this area: 22 28 29 30 39 43 45 50 56 57 67 78 99 104 112 126 137 138 142 145 150 151 152 154 157 160 171 177 180 184 187 189 195 200 208 215 226 228 231
Green Tea and EGCG, Teeth and Oral Cavity: Human Studies
For teeth and the oral cavity, mouth rinses, dental floss and chewing gum with green tea extract lowered dental plaque compared with placebo or usual care 95110111121. Compared with chlorhexidine, they performed the same or somewhat weaker 95110111. Gum bleeding also decreased in two controlled trials 110121. For gum inflammation, however, a meta-analysis saw no confirmed benefit for green tea mouth rinses 14. In periodontitis, gum pocket depth decreased more when EGCG solution served as a coolant during cleaning or a green tea gel was applied 14149173. After tooth extraction, swabs soaked with green tea extract lowered pain and painkiller use compared with saline 122135. In advanced head and neck cancer in palliative treatment, a green tea mouth rinse improved the oral condition, but not pain and quality of life 105. After periodontal surgery, a gel of green tea extract and hyaluronic acid worked as well as chlorhexidine gel and caused fewer taste disturbances and discolorations 133. On the palate after removal of a gum graft, a gel of green tea extract and hyaluronic acid brought no difference in wound healing and pain 191.
| Study | Design · participants | Preparation · dose · duration · comparison | Result |
|---|---|---|---|
| 14 Heuzeroth et al. 2025 | meta-analysis · 814 participants | green tea extract as mouthrinse or local delivery; vs. chlorhexidine, control group, turmeric | Gingival Index reduction in gingivitis: unclear (MD = 0.08; 95% CI = 0.01 to 0.14; P = 0.01); probing depth in periodontitis: unclear (MD=-0.79; 95% CI=-1.29 to -0.29 mm; P = 0.002); Gingival Index in periodontitis: unclear (MD=-0.53; 95% CI=-1.01 to -0.05; P = 0.02) |
| 26 Julien et al. 2026 | systematic review | Green tea as a bioactive agent, among other foods; vs. Sugar-sweetened beverages and sweets as dysbiosis-promoting | Suppression of cariogenic pathways (Streptococcus mutans): improved |
| 44 Woelber et al. 2023 | systematic review | Green tea (beverage) adjunct to non-surgical periodontal therapy; vs. Non-surgical periodontal therapy alone | Pocket probing depth (PPD): improved; Bleeding on probing: improved |
| 95 Sharma et al. 2023 | randomised controlled · 90 participants | 5% Camellia sinensis mouth rinse; 5% mouth rinse, amount not stated; 21 days; vs. 0.2% chlorhexidine and saline | plaque buildup: improved (1.08 ± 0.11); oral halitosis: improved (1.50 ± 0.50); tongue coating: no difference (0.75 ± 0.36) |
| 105 Roy et al. 2026 | randomised controlled · 64 participants | green tea-based mouth rinse; thrice daily; 6 weeks; vs. usual care (control group) | Oral Assessment Guide (OAG): improved (F = 34.32, P = < 0.001); Oral Hygiene Index-Simplified (OHI-S): improved (F = 5.67, P = < 0.001) |
| 110 Sandesh et al. 2026 | randomised controlled · 60 participants | 5% green tea extract-impregnated dental floss; 5% extract, twice daily; 15 days; vs. 5% chlorhexidine floss, waxed floss, toothbrushing only | Plaque index (Turesky Modified Quigley-Hein): improved (0.86 ± 0.11); Plaque reduction vs. chlorhexidine: no difference (p > 0.05); Gingival bleeding (Modified Sulcular Bleeding Index): improved (p ≤ 0.008) |
| 111 Lile et al. 2025 | randomised controlled · 60 participants | mouthrinse with 5% green tea extract; rinsed twice daily for four weeks; 4 weeks; vs. placebo, 0.2% chlorhexidine, 10% propolis | plaque index (Silness-Löe) after 4 weeks: improved (1.12); plaque index versus chlorhexidine: worsened (p = 0.03) |
| 114 Deshpande et al. 2021 | randomised controlled · 60 participants | Green tea mouthwash, partly with ginger; 30 days; vs. Chlorhexidine mouthwash | Gingival index: no difference (P < 0.05); Plaque index: no difference (P < 0.05) |
Further studies in this area: 121 122 125 128 129 133 135 136 149 163 173 174 191
Green Tea and EGCG and Skin: Human Studies
For skin and hair, a mixed picture emerges. According to a meta-analysis, ingested green tea catechins mitigated skin redness after UV irradiation more strongly than placebo 20. Green tea catechins with vitamin C showed no difference in sunburn and skin inflammation after UV irradiation in a controlled study 119. A second study found only protection of the connective tissue protein fibulin-5 118. A mixed preparation of green tea extract, bamboo extract and selenium improved hair density in acute hair loss compared with placebo 103. Which component acted is open. A face cream with green tea extract in chitosan microparticles improved skin elasticity and wrinkles more strongly than a placebo cream in a split-face comparison 139. A cream of EGCG, vitamin E and grape seed procyanidins reduced the affected area in atopic dermatitis faster than the comparison cream 123. The overall picture improved in both groups 123.
| Study | Design · participants | Preparation · dose · duration · comparison | Result |
|---|---|---|---|
| 20 Kapoor et al. 2021 | meta-analysis · 100 participants | Oral green tea catechins (supplement/extract); 6 to 12 weeks; vs. Placebo | Erythema index after UV exposure (MED 1.25-1.30): improved (SMD: -0.35; 95% CI, -0.57 to -0.13; I2 = 4%, p = 0.40); Pooled difference in erythema index vs. placebo: improved (p = 0.002) |
| 33 Śladowska et al. 2025 | systematic review | EGCG alone as saline solution or as shampoo/cream component; vs. Placebo, baseline, or active conventional treatment | Skin symptoms in radiation-induced dermatitis: improved (significant reduction); Seborrheic scalp dermatitis (EGCG shampoo vs. conventional): no difference (similar) |
| 34 Allam et al. 2025 | systematic review | Green tea among other herbal remedies; vs. Conventional treatment or control (unspecified) | hair growth, hair density, hair shedding, patient satisfaction: improved |
| 103 Lacetera et al. 2025 | randomised controlled · 66 participants | Hair'InsideTM: green tea extract, bamboo extract, selenium; 84 days; vs. placebo, randomized, double-blind | anagen hair density: improved (+10.3 and +15.0 hair/cm2); anagen/telogen ratio: improved (+1.8 and +2.7); telogen hair density: improved (–6.3 and -7.6 hair/cm2) |
| 118 Charoenchon et al. 2022 | randomised controlled · 50 participants | Green tea catechins 540 mg plus vitamin C 50 mg or placebo; 540 mg GTC plus 50 mg vitamin C twice daily; 12 weeks; vs. Placebo, double-blind randomized | UVR-induced change in fibulin-5: improved; collagen and elastic fibres in papillary dermis: no difference (P < 0.001); fibrillin-rich microfibrils: no difference (P = 0.02) |
| 119 Farrar et al. 2015 | randomised controlled · 50 participants | Encapsulated green tea extract (540 mg GTC) plus vitamin C; 1350 mg extract (540 mg GTC) + 50 mg vitamin C twice daily (1080 mg GTC/d); 3 months; vs. Placebo, double-blind randomized | Sunburn threshold (minimal erythema dose): no difference (28 (20-28) and 20 (20-28) mJ/cm(2)); Erythema index (AUC): no difference; Neutrophil and CD3+ T-lymphocyte infiltration in skin: no difference (P < 0.01) |
| 123 Patrizi et al. 2016 | randomised controlled · 44 participants | MD2011001 cream containing vitamin E, EGCG and grape seed procyanidins; 28 days; vs. placebo cream | IGA reduction: improved; reduction in affected surface area: improved (significantly faster) |
| 139 Wisuitiprot et al. 2022 | randomised controlled · 29 participants | Green tea extract encapsulated chitosan microparticles (GTP) in emulsion base; 8 weeks, monitored every 2 weeks; vs. Placebo cream on the other half face | Skin elasticity (R2): improved (0.748 ± 0.05 vs 0.722 ± 0.05 at 4th week); Melanin index (skin dullness): improved (placebo =295.60 ± 58.81, GTP =282.70 ± 59.62); Facial wrinkles (photographs): improved |
Further studies in this area: 217 221
Green Tea and EGCG and Cancer: Human Studies
In cancer, the controlled studies predominantly found no difference 65116. With green tea extract, new intestinal adenomas did not occur less often than with placebo 65. In prostate cancer precursors, just as many cancer cases occurred with green tea catechins as with placebo 116. A gene analysis of the intestinal study saw fewer adenomas only in people without a certain transporter gene variant 66. A meta-analysis found recurrence less often with EGCG after removal of intestinal polyps than with placebo 11. A meta-analysis mainly of observational studies found no difference in prostate cancer risk between drinking a lot and a little tea 55. Only above seven cups daily was the risk lower 55. Two meta-analyses of small placebo studies calculated a lower cancer risk for catechin preparations in prostate cancer precursors 1955. Hypothesis: In observational studies, green tea drinking was associated with less frequent ovarian and uterine cancer 60. Such data do not show whether the tea is the cause.
| Study | Design · participants | Preparation · dose · duration · comparison | Result |
|---|---|---|---|
| 11 He et al. 2024 | meta-analysis · 1,389 participants | EGCG (green tea extract) or placebo; long-term; vs. Placebo | colorectal cancer recurrence rate: improved (Z=2.83, p < 0.05) |
| 19 Perletti et al. 2019 | meta-analysis · 223 participants | concentrated green tea catechin extracts; vs. Placebo | prostate cancer risk: improved (risk-ratio = 0.41; 95% CI: 0.19- 0.86; I2 = 0) |
| 49 Grammatikopoulou et al. 2020 | systematic review | Green tea catechins, also in combined supplements; vs. Placebo or other intervention in RCTs | PSA concentration: unclear |
| 55 Guo et al. 2017 | cohort study | Green tea (beverage) or green tea catechins; Categories of green tea intake, >7 cups/day; vs. highest vs. lowest intake category; catechins vs. control | Prostate cancer incidence (highest vs. lowest category): no difference (no statistical significance); Prostate cancer incidence per 1 cup/day increase: improved (P = 0.08); Prostate cancer risk with >7 cups/day: improved (linearly associated with a reduced risk) |
| 60 Butler et al. 2011 | cohort study | Green tea (beverage) and black tea as comparator; vs. Black tea or no tea | Ovarian cancer risk with green tea intake: improved (OR=0.66; 95% CI: 0.54, 0.80); Endometrial cancer risk with green tea intake: improved (OR=0.78, 95% CI: 0.62, 0.98); Ovarian cancer risk with black tea: no difference (OR=0.94, 95% CI: 0.87, 1.02) |
| 65 Seufferlein et al. 2022 | randomised controlled · 1,001 participants | Green tea extract standardized to 150 mg EGCG; 150 mg EGCG twice daily; 3 years; vs. Placebo, double-blind, randomized | Adenoma rate (modified ITT): no difference (55.7% in the placebo and 51.1% in the GTE groups); Adenoma rate (per-protocol): no difference (54.3% (151/278) in the placebo group and 48.3% (129/267) in the GTE group) |
| 79 Biernacka et al. 2019 | randomised controlled · 133 participants | EGCG capsules 600 mg/day or green tea drink; 600 mg/day EGCG; 6 months; vs. Placebo | Serum IGFBP-3: no difference (205.2 ng/ml; 95% confidence interval: -583.3-172.9, P = 0.3); Serum IGF-I, IGF-II, IGFBP-2: no difference |
| 93 Kumar et al. 2015 | randomised controlled · 97 participants | Polyphenon E, decaffeinated green tea catechin mixture; 400 mg EGCG per day; 1 year; vs. Placebo | Prostate cancer cases at one year: no difference (5 of 49 (PolyE) versus 9 of 48 (placebo), P = 0.25); Prostate cancer plus ASAP in men with HGPIN without ASAP: no difference (3 of 26 (PolyE) versus 10 of 25 (placebo), P < 0.024) |
Further studies in this area: 97 116 194 198 202 206 209 216 229 230 231 233
Green Tea and EGCG and Liver: Human Studies
For the liver, the picture is inconsistent: Together with brisk walking, AST decreased with green tea extract, but not with placebo 145. With high-dose extract, however, ALT increased, particularly strongly with a certain gene variant 64. A decaffeinated green tea extract confection did not change liver values compared with placebo in healthy people and people with metabolic syndrome 126. In an open-label study, young women received EGCG alone or with clomiphene or letrozole; none showed signs of liver damage 131. Hypothesis: A systematic review, partly with animal studies, sees in EGCG and green tea extract a possible help for fatty liver 46. Hypothesis: A systematic review on polyphenols in fatty liver reports improved liver values for green tea extract 7. Still open is which amount of extract burdens the liver and who, for instance because of their genes, reacts particularly sensitively.
| Study | Design · participants | Preparation · dose · duration · comparison | Result |
|---|---|---|---|
| 7 Ranneh et al. 2024 | systematic review · 1,840 participants | Polyphenol dietary supplementation, including green tea extract; vs. various polyphenol supplements versus control or each other | liver enzymes: improved |
| 15 Brooks et al. 2026 | systematic review · 785 participants | Polyphenol supplements incl. EGCG, curcumin, silymarin, cranberry; vs. Control groups of included trials | Hepatoprotective effects of silymarin: improved (potential hepatoprotective effects) |
| 46 Abunofal et al. 2022 | systematic review | EGCG or green tea extract (GTE) | lipid and glucose metabolism, expression of lipid synthesis genes: improved; oxidative stress and pro-inflammatory pathways, liver damage: improved |
| 64 Acosta et al. 2023 | randomised controlled · 1,075 participants | High-dose green tea extract (capsules) with 843 mg EGCG/day; 843 mg EGCG/day; 12 months; vs. Placebo capsules | AST:ALT ratio change from baseline to month 3: worsened (+1.0% vs -4.8% (p = 0.03)); ALT change from baseline to month 6: worsened (+78.1% vs +28.0% (p < 0.001)); ALT change from baseline to month 9: worsened (+82.1% vs +30.1% (p = 0.004)) |
| 112 Pormlikul et al. 2025 | randomised controlled · 60 participants | Green tea beverage vs. placebo beverage; 6 weeks; vs. Placebo beverage, randomized double-blind | Liver function tests: no difference (no alterations) |
| 126 Zeng et al. 2024 | randomised controlled · 40 participants | Decaffeinated green tea extract confection; 890 mg total catechins per day; 4 weeks; vs. Placebo, double-blind, crossover | Plasma aminotransferases: no difference (P > .05) |
| 145 Zhang et al. 2020 | randomised controlled · 24 participants | green tea extract (GTE) tablets; 2 tablets of 150 mg GTE daily; 12-week intervention, 4-week follow-up; vs. placebo plus brisk walking | aspartate aminotransferase: improved (P < 0.01) |
| 199 He et al. 2025 | study | Polyphenon E (Theaphenon E), green tea polyphenol extract; 400, 800, 1,200, 1,600, 2,000 mg EGCG daily; 24 weeks; vs. Dose escalation, 3+3 design, no control group | Liver γ-OHPdG levels: improved; VCTE-controlled attenuation parameter: improved |
Further studies in this area: 222 227
Green Tea and EGCG: Further Outcomes in Studies
Green tea extract lowered CRP compared with placebo in hospitalized patients with COVID-19 and in overweight women after menopause 101140. A meta-analysis and a one-year study with high-dose extract, however, found no difference in CRP, IL-6 and TNF-alpha 3690. Meta-analyses found a higher antioxidant capacity in the blood with green tea supplementation and mostly less malondialdehyde, a marker of oxidative stress 51636. In a one-year extract study, F2-isoprostanes, another marker, remained unchanged 178. In painful diabetic nerve damage, green tea extract relieved pain more strongly than placebo 75. A green tea ointment after episiotomy showed no confirmed group difference 113. Two placebo-controlled matcha studies showed only tendencies in sleep quality and mood; in the sleep EEG, no difference was found 89176. A heat-treated green tea extract improved memory more strongly than placebo in people with subjective memory problems 98. Matcha and decaffeinated catechins improved individual attention and working memory tests 124186. In older people with cognitive decline, the main measures remained unchanged with matcha 89. Investigated were mainly green tea extract in capsules or tablets, matcha powder 89176 and decaffeinated extract 126186. Statements on dose, preparation and duration remain open, since the studies used very different forms, amounts and comparison groups.
| Study | Design · participants | Preparation · dose · duration · comparison | Result |
|---|---|---|---|
| 4 Long et al. 2023 | meta-analysis · 3,852 participants | Tea polyphenols among 14 other polyphenol sources; vs. Control without added polyphenols | Disease activity score (DAS28): improved; Inflammation markers (CRP, ESR): improved; Oxidative stress: improved |
| 5 Asbaghi et al. 2024 | meta-analysis · 3,802 participants | green tea extract (GTE) as dietary supplement; vs. placebo or control | malondialdehyde (MDA): improved (significantly reduced); total antioxidant capacity (TAC): improved (increased) |
| 7 Ranneh et al. 2024 | systematic review · 1,840 participants | Polyphenol dietary supplementation, including green tea extract; vs. various polyphenol supplements versus control or each other | inflammatory cytokines: improved |
| 15 Brooks et al. 2026 | systematic review · 785 participants | Polyphenol supplements incl. EGCG, curcumin, silymarin, cranberry; vs. Control groups of included trials | Disability (EDSS) with EGCG: no difference (no significant impact on disability); Relapse rate with EGCG: no difference (no significant impact on ... relapse rates); MRI changes with EGCG: no difference (no significant impact on ... MRI outcomes) |
| 16 Rasaei et al. 2021 | meta-analysis · 760 participants | Green tea supplementation (form not further specified in abstract); Dose in mg/day examined in meta-regression, specific values not reported; Intervention duration in weeks examined in meta-regression, specific values not reported; vs. Control group (placebo or no supplementation) | Total antioxidant capacity (TAC): improved (WMD: 0.20 mmol/L; 95% CI: 0.09, 0.30, p < 0.001); Malondialdehyde (MDA): no difference; MDA dose-response association (meta-regression): improved (r = -2117.18, p = 0.017) |
| 24 Wójtowicz et al. 2026 | systematic review | Dietary supplements, including EGCG; vs. Placebo in randomized trials | Endometriotic lesion size (animal and human studies): unclear; RCT efficacy of EGCG in endometriosis: unclear (no RCTs evaluating the effectiveness of ... EGCG) |
| 25 Marsh et al. 2026 | systematic review | Camellia sinensis (green tea), form not specified; vs. placebo or control in included RCTs | processing speed, attention, working memory, language, psychomotor function, overall cognitive performance: no difference (no benefit) |
| 27 Payne et al. 2025 | meta-analysis | Tea, theanine alone, or theanine plus caffeine; vs. Placebo | Choice reaction time (hour 1): improved (SMD, -0.48; 95% CI, -1.01, 0.05); Digit vigilance task accuracy (hour 2): improved (SMD, 0.20; 95% CI, 0.02, 0.38); Attention switching task accuracy (hour 2): improved (SMD, 0.33; 95% CI, 0.13, 0.54) |
Further studies in this area: 31 32 35 36 40 41 42 48 51 52 54 58 61 62 69 71 72 73 74 75 76 80 81 82 83 84 86 87 88 89 90 92 93 94 96 98 100 101 102 105 106 107 108 109 113 116 117 124 126 127 130 132 134 137 138 140 141 143 146 147 151 153 155 156 157 162 165 169 170 171 172 174 176 177 178 179 180 181 182 183 185 186 188 189 190 192 193 196 197 198 199 200 201 202 203 204 207 208 210 212 214 215 217 218 219 220 221 223 225 231 234
4. How Is Green Tea and EGCG Dosed? Preparation, Dose and Duration in Studies
The infusion from the leaves, green tea extract in capsules or tablets, decaffeinated extract, EGCG-enriched extract and ground leaf powder were studied. For teeth and the oral cavity, mouth rinses, gels, chewing gum, dental floss and soaked pads were also used. Some of the studies tested combination preparations, for example with vitamin C, selenium or hyaluronic acid, or green tea together with exercise. They say nothing about the tea alone.
| Preparation or form | Dose | Duration | Study |
|---|---|---|---|
| High-dose green tea extract (capsules) with 843 mg EGCG/day | 843 mg EGCG/day | 12 months | 64 |
| Green tea extract standardized to 150 mg EGCG | 150 mg EGCG twice daily | 3 years | 65 |
| Green tea extract (capsules) versus placebo | — | 3 years | 66 |
| Green tea extract capsules (two each morning and evening with meals) | 843 mg/day EGCG | 12 months | 67 |
| Green-MED diet with green tea (3-4 cups/day) plus Mankai shake and walnuts | 3-4 cups green tea per day | 18 months | 68 |
| green-MED diet with green tea, walnuts, Mankai | +1240 mg/day polyphenols from walnuts, Mankai, green tea | 18 months | 69 |
| Green-MED diet with green tea (3-4 cups/d) and Mankai shake | 3-4 cups green tea per day | 18 months | 70 |
| Green-MED diet with green tea (3-4 cups/day), Mankai and walnuts | 3-4 cups green tea daily | 18 months | 71 |
| Beverage with catechins and xanthan gum | high: 3×57 mg catechins + 100 mg xanthan; low: 1×57 mg + 100 mg xanthan | 12 weeks (December 2017 to February 2018) | 72 |
| Green tea extract capsules, 843 mg EGCG daily | 843 mg EGCG daily, two capsules twice daily | 12 months | 73 |
| Capsules with green tea catechins and theanine | 378 mg catechins and 210 mg theanine per day | 5 months | 74 |
| Green tea extract (GTE) | — | 16 weeks | 75 |
| Green tea extract capsules with 843.0 mg EGCG or placebo | 843.0 mg EGCG daily | 12 months | 76 |
| oral L-theanine (green tea amino acid) | — | single dose, measured 60 minutes before and after | 77 |
| Yabukita or Benifuuki green tea extract powder in capsules | 1.8 g/day | 12 weeks | 78 |
5. Is Green Tea and EGCG Safe? Side Effects in Studies
In a large placebo-controlled trial, green tea extract was well tolerated, with no substantial differences in adverse events 65. However, high-dose green tea extract can stress the liver. In a large trial, liver values (ALT) rose with it, and markedly more so with a particular gene variant 64. A meta-analysis advises caution with concentrated extracts and, if necessary, monitoring of liver values 12. In a small open-label trial with EGCG, no woman showed signs of liver damage 131. In small trials, green tea and green tea extract led to lower blood levels of nadolol, lisinopril, atorvastatin, rosuvastatin, fexofenadine and nintedanib 144148161164166168.
| Study | Reported side effects |
|---|---|
| 3 Lagou et al. 2025 | minor and low (0.4%) |
| 4 Long et al. 2023 | Adding polyphenols did not increase adverse events |
| 12 Zago et al. 2026 | Caution with high-dose extracts, monitor hepatic function |
| 15 Brooks et al. 2026 | Intervention adverse events generally mild |
| 16 Rasaei et al. 2021 | not reported |
| 23 Andrés et al. 2026 | Most interventions were well tolerated at the nutritional doses tested |
| 31 Ufomadu et al. 2025 | Adverse skin reactions reported |
| 32 Liang et al. 2025 | SAEs rare but reported for Camellia sinensis |
| 33 Śladowska et al. 2025 | Generally well tolerated, no serious treatment-related adverse events |
| 36 Dehzad et al. 2025 | not reported |
| 47 Willcox et al. 2021 | no serious adverse effects reported |
| 51 Marx et al. 2020 | Adverse events reported for green tea and inosine; caution advised |
6. What Remains Open: Limits of the Evidence
- The controlled trials are mostly small and short, so long-term effects remain open.
- Caffeine content and optimal preparation were rarely compared systematically.
- Many findings come from combination preparations and cannot be attributed to green tea or EGCG alone.
- For cancer and the liver, it is unclear which form and amount of EGCG has a favorable or unfavorable effect.
- Interactions with medicines have been studied only for individual active substances.
7. Bottom Line: What Is Established About Green Tea and EGCG
Green tea and its catechins, especially EGCG, have been studied extensively in controlled trials in humans. The clearest are small reductions in total and LDL cholesterol, blood pressure and body weight in meta-analyses 56910. Mouth rinses, dental floss and chewing gum with green tea extract reduced dental plaque and gum bleeding 95110111121.
For cancer, the controlled trials mostly found no difference 65116. The studies are mostly small and short and use very different forms and amounts. Combination preparations do not allow any statement about the tea alone. Interactions with medicines and possible liver stress with high-dose extracts should be noted 1264164168.
Frequently Asked Questions
How well has Green Tea and EGCG been studied in humans?
We evaluated 265 human studies on Green Tea and EGCG, including 156 randomised controlled trials and 61 meta-analyses or systematic reviews; the controlled studies include 12,147 participants in total. As of 5 October 2026.
Does Green Tea and EGCG help with body weight and metabolism? What the studies show
Does Green Tea and EGCG help with heart and circulation? What the studies show
Does Green Tea and EGCG help with teeth and oral cavity? What the studies show
Does Green Tea and EGCG help with skin? What the studies show
Does Green Tea and EGCG help with cancer? What the studies show
Does Green Tea and EGCG help with liver? What the studies show
Does green tea help with weight loss?
Meta-analyses found only a slight decrease in body weight, BMI and body fat percentage with green tea extract 537; drinks with added catechins reduced abdominal fat 1385. One meta-analysis found no weight difference outside Japan, and a decaffeinated catechin extract did not change weight over one year 5991.
Does green tea lower blood sugar?
Does green tea help against caries and gum inflammation?
Can green tea prevent cancer?
For cancer, the controlled trials mostly found no difference 65116. With green tea extract, new bowel adenomas did not occur less often than with placebo 65. For prostate cancer precursors, with green tea catechins as many cancer cases occurred as with placebo 116. One meta-analysis found less frequent recurrence with EGCG after removal of bowel polyps 11; in hereditary polyposis, green tea extract showed only a non-confirmed trend 97. Whether drink or extract and which amount of EGCG has an effect remains open.
Is green tea extract safe?
In the controlled trials, green tea extract was mostly well tolerated 6591. However, high-dose extracts can increase liver values 64; a meta-analysis advises caution here and monitoring of liver values 12. Green tea and extract can also reduce the absorption of medicines such as nadolol and lisinopril 164168.
Sources
- 1Wang R, Huang K, Wang M, Zou W, Huang Y, Jiang W et al. · 2025
- 2Osadnik T, Goławski M, Lewandowski P, Morze J, Osadnik K, Pawlas N et al. · 2022
- 3Lagou V, Greyling A, Ferruzzi MG, Skene SS, Dubost J, Demirkan A et al. · 2025
- 4Long Z, Xiang W, He Q, Xiao W, Wei H, Li H et al. · 2023
- 5Asbaghi O, Rezaei Kelishadi M, Larky DA, Bagheri R, Amirani N, Goudarzi K et al. · 2024
- 6Xu R, Yang K, Li S, Dai M, Chen G · 2020
- 7Ranneh Y, Bedir AS, Abu-Elsaoud AM, Al Raish S · 2024
- 8Jayedi A, Norouziasl R, Aletaha A, Mirrafiei A, Soltani A, Shab-Bidar S · 2024
- 9Xu R, Yang K, Ding J, Chen G · 2020
- 10Kim A, Chiu A, Barone MK, Avino D, Wang F, Coleman CI et al. · 2011
- 11He B, Kang S, Su R, Wu S, Liu X, Liu M et al. · 2024
- 12Zago IHR, Colonetti L, Balbinot EL, Taschetto IS, Grande AJ, da Rosa MI et al. · 2026
- 13Hibi M, Takase H, Iwasaki M, Osaki N, Katsuragi Y · 2018
- 14Heuzeroth G, Kaufmann ME, Herter-Aeberli I, Schlagenauf U, Liu CC, Papageorgiou SN et al. · 2025
- 15Brooks L, Farid AFBA, Poobalan A, Johnstone A, Myint PK · 2026
- 16Rasaei N, Asbaghi O, Samadi M, Setayesh L, Bagheri R, Gholami F et al. · 2021
- 17Jia MJ, Liu XN, Liang YC, Liu DL, Li HL · 2024
- 18Wang Y, Xia H, Yu J, Sui J, Pan D, Wang S et al. · 2023
- 19Perletti G, Magri V, Vral A, Stamatiou K, Trinchieri A · 2019
- 20Kapoor MP, Sugita M, Fukuzawa Y, Timm D, Ozeki M, Okubo T · 2021
- 21Khalilkhaneh AH, Bidsheki MV, Zebari SMS, Talebi S, Mohajerani A, Djafarian K · 2026
- 22Paparozzi J, Barroca C, Gogerdchian H, Girdler M, Akel M, Prashar S · 2026
- 23Andrés CMC, Lastra JMP, Bustamante Munguira E, Juan CA, Lebeña EP · 2026
- 24Wójtowicz M, Małek P, Olszanecka-Glinianowicz M · 2026
- 25Marsh A, Quelch D, Mackonochie M, Hejmadi M, Rolfe V · 2026
- 26Julien V, Carvalho JP, Andrade JC, Rodrigues CF, Rajão A · 2026
- 27Payne ER, Aceves-Martins M, Dubost J, Greyling A, de Roos B · 2025
- 28Frumuzachi O, Babotă M, Miere D, Mocan A, Crișan G · 2025
- 29Rezaei M, Akhavan N, Fathi F, Alavi SM, Fadaii M, Dehzad MJ et al. · 2025
- 30Ghoflchi S, Mohammadi H, Teimouri M, Imani M, Hosseini H · 2025
- 31A Review of The Efficacy of Complementary and Alternative Medicines in Managing Dermatologic Infectious DiseasesUfomadu P, Gill BJ, Shimizu I, Orengo I, Rosen T · 2025
- 32Liang CJW, Woerdenbag HJ, Ekhart C, Vitalone A, van Hunsel FPAM · 2025
- 33Śladowska K, Moćko P, Brzostek T, Malinowska-Lipień I, Owca M, Kawalec P · 2025
- 34Allam AT, El-Shiekh RA, El-Dessouki AM, Gamil NM, Eisa NM, Ayoub MM et al. · 2025
- 35Cavanah AM, Robinson LA, Mattingly ML, Frugé AD · 2025
- 36Dehzad MJ, Ghalandari H, Nouri M, Makhtoomi M, Askarpour M · 2025
- 37Dehzad MJ, Ghalandari H, Fahimzad FS, Maghsoudi Z, Makhtoomi M, Nouri M et al. · 2025
- 38Saadh MJ, Gataa IS, Hussam AS, Kaur I, Kumar A, Godara P et al. · 2025
- 39
- 40Zhang Y, Liu C, Zhu Q, Wu H, Liu Z, Zeng L · 2025
- 41
- 42de Oliveira Assis FS, Vasconcellos GL, Lopes DJP, de Macedo LR, Silva M · 2024
- 43Gholami F, Antonio J, Iranpour M, Curtis J, Pereira F · 2024
- 44Woelber JP, Reichenbächer K, Groß T, Vach K, Ratka-Krüger P, Bartha V · 2023
- 45Zamani M, Kelishadi MR, Ashtary-Larky D, Amirani N, Goudarzi K, Torki IA et al. · 2022
- 46Abunofal O, Mohan C · 2022
- 47Willcox ML, Elugbaju C, Al-Anbaki M, Lown M, Graz B · 2021
- 48d'Unienville NMA, Blake HT, Coates AM, Hill AM, Hill AM, Nelson MJ et al. · 2021
- 49Grammatikopoulou MG, Gkiouras K, Papageorgiou SΤ, Myrogiannis I, Mykoniatis I, Papamitsou T et al. · 2020
- 50Asbaghi O, Fouladvand F, Moradi S, Ashtary-Larky D, Choghakhori R, Abbasnezhad A · 2020
- 51Marx W, Hockey M, McGuinness AJ, Lane M, Christodoulou J, van der Mei I et al. · 2020
- 52Cicero AFG, Fogacci F, Banach M · 2018
- 53Kapoor MP, Sugita M, Fukuzawa Y, Okubo T · 2017
- 54Mancini E, Beglinger C, Drewe J, Zanchi D, Lang UE, Borgwardt S · 2017
- 55Guo Y, Zhi F, Chen P, Zhao K, Xiang H, Mao Q et al. · 2017
- 56Serban C, Sahebkar A, Antal D, Ursoniu S, Banach M · 2015
- 57Khalesi S, Sun J, Buys N, Jamshidi A, Nikbakht-Nasrabadi E, Khosravi-Boroujeni H · 2014
- 58Camfield DA, Stough C, Farrimond J, Scholey AB · 2014
- 59Jurgens TM, Whelan AM, Killian L, Doucette S, Kirk S, Foy E · 2012
- 60Butler LM, Wu AH · 2011
- 61Tzellos TG, Sardeli C, Lallas A, Papazisis G, Chourdakis M, Kouvelas D · 2011
- 62Antioxidants and antiinflammatory dietary supplements for osteoarthritis and rheumatoid arthritisRosenbaum CC, O'Mathúna DP, Chavez M, Shields K · 2010
- 63Complementary and alternative medicine for the treatment of type 2 diabetesNahas R, Moher M · 2009
- 64Acosta L, Byham-Gray L, Kurzer M, Samavat H · 2023
- 65Seufferlein T, Ettrich TJ, Menzler S, Messmann H, Kleber G, Zipprich A et al. · 2022
- 66Stingl J, Scholl C, Steffens M, Koczera P, Muche R, Rohlmann F et al. · 2025
- 67The Effect of 12-Month Green Tea Extract Supplementation and Impact of Catechol-O-Methyltransferase Genotype on Blood Pressure in Women Who Are Post-menopause· 2021
- 68Zelicha H, Keller M, Meir AY, Rinott E, Tsaban G, Kaplan A et al. · 2026
- 69Pachter D, Yaskolka Meir A, Kaplan A, Tsaban G, Zelicha H, Rinott E et al. · 2025
- 70Pachter D, Kaplan A, Tsaban G, Zelicha H, Meir AY, Rinott E et al. · 2024
- 71Kaplan A, Zelicha H, Yaskolka Meir A, Rinott E, Tsaban G, Levakov G et al. · 2022
- 72Furushima D, Nishimura T, Takuma N, Iketani R, Mizuno T, Matsui Y et al. · 2019
- 73Effect of Green Tea Extract Supplementation and Impact of Catechol-O-Methyltransferase Genotype on Plasma Concentration of F2-Isoprostanes in Women Who Are Post-menopause· 2022
- 74Matsumoto K, Yamada H, Takuma N, Niino H, Sagesaka YM · 2011
- 75Essmat A, Hussein MS · 2021
- 76The Effect of Green Tea Extract Supplementation and Different Catechol-O-Methyltransferase Genotypes on Plasma Catechins Concentrations in Women Who Are Post-menopause· 2022
- 77Deshpande SS, Kurdi M, Baiju A, Athira AS, Sarasamma AG, Gangadharan AK · 2025
- 78Igarashi Y, Obara T, Ishikuro M, Matsubara H, Shigihara M, Metoki H et al. · 2017
- 79Biernacka KM, Holly JMP, Martin RM, Frankow A, Bull CJ, Hamdy FC et al. · 2019
- 80Sandu MR, Beynon R, Richmond R, Santos Ferreira DL, Hackshaw-McGeagh L, Davey Smith G et al. · 2019
- 81Lane JA, Lane JA, Er V, Avery KNL, Horwood J, Cantwell M et al. · 2018
- 82Forcano L, Soldevila-Domenech N, Boronat A, Sánchez-Benavides G, Puig-Pijoan A, Lorenzo T et al. · 2025
- 83Wightman E, Khan J, Smith E, Rolfe V, Smith D, Young G et al. · 2023
- 84Beynon RA, Richmond RC, Santos Ferreira DL, Ness AR, May M, Smith GD et al. · 2019
- 85Kobayashi M, Kawano T, Ukawa Y, Sagesaka YM, Fukuhara I · 2016
- 86de Oliveira Vogado C, Ferreira MA, Nakano EY, Azevedo S, Magalhães KG, Fernandes Arruda S et al. · 2024
- 87Furushima D, Sugiyama I, Nomura Y, Unno K, Yamada H · 2022
- 88Zhu W, Jia L, Qiao Q, Li X, Peng X, Meng X et al. · 2026
- 89Uchida K, Meno K, Korenaga T, Liu S, Suzuki H, Baba Y et al. · 2024
- 90Cunningham A, Gomes A, Meng L, Shapses S, Byham-Gray L, Samavat H · 2026
- 91Kumar NB, Patel R, Pow-Sang J, Spiess PE, Salup R, Williams CR et al. · 2017
- 92Kumar NB, Pow-Sang J, Spiess PE, Park J, Salup R, Williams CR et al. · 2016
- 93Kumar NB, Pow-Sang J, Egan KM, Spiess PE, Dickinson S, Salup R et al. · 2015
- 94Park SK, Jung IC, Lee WK, Lee YS, Park HK, Go HJ et al. · 2011
- 95Sharma P, Chandrashekar BR, Mruthunjaya K, Bhaskar V · 2023
- 96Tubbs AS, Kennedy KER, Alfonso-Miller P, Wills CCA, Grandner MA · 2021
- 97Ishikawa H, Mutoh M, Yamane T, Wakabayashi K, Hirata K, Iwama T et al. · 2026
- 98Joo Y, Lee H, Jeong H, Suh C, Hong H, Kim Y et al. · 2025
- 99Lee TM, Charng MJ, Tseng CD, Lai LP · 2016
- 100Makizako H, Shiratsuchi D, Miyake Y, Tabira K, Tateishi M, Akaida S et al. · 2026
- 101Yousefi M, Hosseinzade Z, Mahmoodi S, Mahmoodabadi A, Pourmahmoudi A, Saeedinejad Z et al. · 2024
- 102Kheirabadi Z, Mehrabani M, Sarafzadeh F, Dabaghzadeh F, Ahmadinia N · 2019
- 103Lacetera J, Pouchieu C, Pourtau L, Monchaux de Oliveira C, Roveda G, Nobile V · 2025
- 104Yazdanpanah Z, Salehi-Abargouei A, Mozaffari Z, Hemayati R · 2023
- 105
- 106Cavanah AM, Robinson LA, Aguilar MM, Molaison EF, Greene MW, Roberts MD et al. · 2026
- 107Gutiérrez-Romero SA, Torres-Narváez ES, Zamora-Gómez AC, Castillo-Castillo S, Latorre-Velásquez AL, Betancourt-Villamizar C et al. · 2023
- 108Yao D, Xie L, Du K, Yao X, Shen X · 2024
- 109Xie L, Tang Q, Yao D, Gu Q, Zheng H, Wang X et al. · 2021
- 110Sandesh N, Johar R, Mishra P, Gupta D, Sontakke S · 2026
- 111Lile IE, Hajaj T, Veja I, Hosszu T, Vaida LL, Todor L et al. · 2025
- 112Pormlikul T, On-Nom N, Suttisansanee U, Temviriyanukul P, Trachootham D, Khemthong C et al. · 2025
- 113Sayahi M, Jahangirimehr A, Hatami Manesh Z, Mojab F, Nikbina M · 2024
- 114Deshpande A, Deshpande N, Raol R, Patel K, Jaiswal V, Wadhwa M · 2021
- 115Dostal AM, Arikawa A, Espejo L, Bedell S, Kurzer MS, Stendell-Hollis NR · 2017
- 116Micali S, Territo A, Pirola GM, Ferrari N, Sighinolfi MC, Martorana E et al. · 2017
- 117
- 118Charoenchon N, Rhodes LE, Nicolaou A, Williamson G, Watson REB, Farrar MD · 2022
- 119Farrar MD, Nicolaou A, Clarke KA, Mason S, Massey KA, Dew TP et al. · 2015
- 120Moran-Lev H, Cohen S, Zelber-Sagi S, Mazkeret Mayer E, Anafy A, Yerushalmy-Feler A et al. · 2023
- 121The Efficacy of Green Tea Chewing Gum on Gingival InflammationBehfarnia P, Aslani A, Jamshidian F, Noohi S · 2016
- 122
- 123Patrizi A, Raone B, Neri I, Gurioli C, Carbonara M, Cassano N et al. · 2016
- 124
- 125Singh S, Alok A, Shahnawaz K, Kumar S, Ramdas Naik S, Piyush K · 2026
- 126Zeng M, Hodges JK, Pokala A, Khalafi M, Sasaki GY, Pierson J et al. · 2024
- 127Pickering G, Noah L, Pereira B, Goubayon J, Leray V, Touron A et al. · 2023
- 128Thakur N, Kumar V, Agarwal A, Kumari S · 2021
- 129
- 130Johnson JJ, Siblini H, Al-Hendy A, Segars JH, González F, Taylor HS et al. · 2025
- 131Siblini H, Al-Hendy A, Segars J, González F, Taylor HS, Singh B et al. · 2023
- 132Barocio-Pantoja M, Quezada-Fernández P, Cardona-Müller D, Jiménez-Cázarez MB, Larios-Cárdenas M, González-Radillo OI et al. · 2021
- 133Gonçalves LS, Melo SS, de Oliveira GJPL, Figueiredo LC, Bezerra FJB, Furlaneto FAC et al. · 2026
- 134Cha J, Kim HS, Kwon G, Cho SY, Kim JM · 2023
- 135Etemadi Sh M, Haghighat A, Fattahi B, Tajmiri G, Alizargar J · 2023
- 136Rezvani G, Taleghani F, Valizadeh M · 2022
- 137Bagheri R, Rashidlamir A, Ashtary-Larky D, Wong A, Alipour M, Motevalli MS et al. · 2020
- 138Arazi H, Taati B, Kheirkhah J, Ramezanpour S · 2019
- 139Wisuitiprot W, Ingkaninan K, Jones S, Waranuch N · 2022
- 140Rondanelli M, Gasparri C, Perna S, Petrangolini G, Allegrini P, Fazia T et al. · 2022
- 141Settakorn K, Hantrakool S, Petiwathayakorn T, Hutachok N, Tantiworawit A, Charoenkwan P et al. · 2023
- 142Roberts JD, Willmott AGB, Beasley L, Boal M, Davies R, Martin L et al. · 2021
- 143Karl JP, Fagnant HS, Radcliffe PN, Wilson M, Karis AJ, Sayers B et al. · 2025
- 144Veerman GDM, van der Werff SC, Koolen SLW, Miedema JR, Oomen-de Hoop E, van der Mark SC et al. · 2022
- 145Zhang T, Li N, Chen SI, Hou Z, Saito A · 2020
- 146Dietz C, Dekker M, Piqueras-Fiszman B · 2017
- 147Mixed Flavonoid Supplementation Attenuates Post-Exercise Plasma Levels of Protein Carbonyls and 4-Hydroxynonenal Protein Adducts Levels in Endurance Athletes (P23-009-19)Wentz L, Nieman D, Valacchi G, Ferrara F, Woodby B, Sakaguchi C et al. · 2019
- 148Zeng W, Hu M, Lee HK, Wat E, Lau CBS, Ho CS et al. · 2022
- 149
- 150Quezada-Fernández P, Trujillo-Quiros J, Pascoe-González S, Trujillo-Rangel WA, Cardona-Müller D, Ramos-Becerra CG et al. · 2019
- 151Stote KS, Clevidence BA, Novotny JA, Henderson T, Radecki SV, Baer DJ · 2012
- 152Suzuki-Sugihara N, Kishimoto Y, Saita E, Taguchi C, Kobayashi M, Ichitani M et al. · 2016
- 153Watanabe J, Kobayashi F, Tahara M, Kitabayashi H, Shiozawa M, Kondo S et al. · 2024
- 154Zhang C, Zhang J, Li D, Hu X · 2024
- 155Aguree S, Turi KN, Handt AR, Kohut M, Reddy MB · 2026
- 156Demirli A, Ulupınar S, Terzi M, Özbay S, Özkara AB, Gençoğlu C et al. · 2025
- 157Sapper TN, Mah E, Ahn-Jarvis J, McDonald JD, Chitchumroonchokchai C, Reverri EJ et al. · 2016
- 158Sulaimani N, Rosbotham EJ, Warnock R, Polzella L, Judowski R, Nicolotti L et al. · 2025
- 159Hursel R, Janssens PL, Bouwman FG, Mariman EC, Westerterp-Plantenga MS · 2014
- 160Din USU, Sian TS, Deane CS, Smith K, Gates A, Lund JN et al. · 2021
- 161Abdelkawy KS, Abdelaziz RM, Abdelmageed AM, Donia AM, El-Khodary NM · 2020
- 162Dimpfel W, Kler A, Kriesl E, Lehnfeld R, Keplinger-Dimpfel IK · 2007
- 163Alves HC, Gomes EAB, Uchoa AFJ, Ricardo NMPS, Passos VF, Santiago SL · 2025
- 164Misaka S, Abe O, Ono T, Ono Y, Ogata H, Miura I et al. · 2020
- 165Singh P, Griffith I, Tanksley M, Beyl RA, Greenway F · 2026
- 166Misaka S, Ono Y, Taudte RV, Hoier E, Ogata H, Ono T et al. · 2022
- 167Ishikawa A, Matsuda T, Gam H, Kanno M, Yamada M, Ikegami N et al. · 2022
- 168Misaka S, Ono Y, Uchida A, Ono T, Abe O, Ogata H et al. · 2021
- 169Kawakami Y, Yasuda A, Hayashi M, Akiyama M, Asai T, Hosaka T et al. · 2021
- 170Carmichael OT, Pillai S, Shankapal P, McLellan A, Kay DG, Gold BT et al. · 2018
- 171Churm R, Williams LM, Dunseath G, Prior SL, Bracken RM · 2023
- 172Bonifácio DB, Macedo Fraiz G, Lacerda UV, Cardoso RR, Pelissari Kravchychyn AC, Corich V et al. · 2025
- 173Rengaraj S, Thilagar SS, Yadalam PK, Pampani P, Mani E, Ardila CM · 2025
- 174Fraiz GM, Bonifácio DB, Lacerda UV, Cardoso RR, Corich V, Giacomini A et al. · 2024
- 175Jardon KM, Goossens GH, Most J, Galazzo G, Venema K, Penders J et al. · 2024
- 176Baba Y, Takihara T, Okamura N · 2024
- 177Petiwathayakorn T, Hantrakool S, Settakorn K, Hutachok N, Tantiworawit A, Chalortham N et al. · 2024
- 178Bathgate JR, Radler DR, Kurzer M, Samavat H · 2023
- 179Takamata A, Oka A, Nagata M, Kosugi N, Eguchi S, Sakagawa N et al. · 2023
- 180Machin A, Suprapto DA, Hanifah A, Suharjanti I, Shodiq J, Fatihuddin MF et al. · 2023
- 181Noah L, Morel V, Bertin C, Pouteau E, Macian N, Dualé C et al. · 2022
- 182A Combination of Magnesium, B Vitamins, Rhodiola, and Green Tea (L-theanine) Alleviates Chronic Stress in Healthy Volunteers: A Randomized, Placebo-Controlled Study· 2022
- 183Sadeghian M, Torabi A, Torabi S, Vafadar M, Oladi S · 2022
- 184The Effect of Green Tea Extract on Individual Components of Metabolic Syndrome in Women Who Are Post-menopause· 2021
- 185Seo H, Lee SH, Park Y, Lee HS, Hong JS, Lim CY et al. · 2021
- 186Baba Y, Inagaki S, Nakagawa S, Kaneko T, Kobayashi M, Takihara T · 2020
- 187Angiletta CJ, Griffin LE, Steele CN, Baer DJ, Novotny JA, Davy KP et al. · 2018
- 188Small BJ, Rawson KS, Martin C, Eisel SL, Sanberg CD, McEvoy CL et al. · 2014
- 189Brown AL, Lane J, Holyoak C, Nicol B, Mayes AE, Dadd T · 2011
- 190Double-blind, placebo-controlled study of Fertilityblend: a nutritional supplement for improving fertility in womenWestphal LM, Polan ML, Trant AS · 2006
- 191Oliveira JA, da Silveira MI, de Oliveira Alves R, Bezerra FJB, de Oliveira GJPL, Pigossi SC · 2023
- 192A nutritional supplement for improving fertility in women: a pilot studyWestphal LM, Polan ML, Trant AS, Mooney SB · 2004
- 193Melzer A, Sturm N, Rohlmann F, Muche R, Stingl J, Ettrich TJ et al. · 2025
- 194Gersekowski K, DeFazio A, Friedlander M, Obermair A, Webb PM · 2025
- 195
- 196Marino C, Magliocchetti M, Di Lieto D, Cione E, Vocca C, Ceccato T et al. · 2026
- 197Cognitive and transcriptomic effects of Epigallocatechin gallate in fetal alcohol spectrum disordersRamos-Triguero A, Astals-Vizcaino M, Navarro-Tapia E, Vieiros M, Bastons-Compta A, Martínez L et al. · 2026
- 198Li X, Zhang Q, Zhang H, Li P, Zhu S, Zhang S et al. · 2026
- 199He AR, Smith CI, Cruz-Correa M, Chakraborty R, Zhang S, Sang S et al. · 2025
- 200Akif A, Munami JW, Das R, Shawon NJ · 2026
- 201
- 202
- 203Michońska I, Serwin A, Dereń K · 2026
- 204Jeong SH, Shin JY, Lee PH · 2026
- 205Bashir S, Shah IM, Javeed S, Rafiquee A, Mir B, Hassan Mir R et al. · 2026
- 206Arjona-Ruiz C, Valdez-Morales EE, Guerrero-Alba R · 2026
- 207Farzana HR, Vigriawan GE, Santini A, Nurkolis F · 2026
- 208
- 209Altinoz HB, Sanlier N · 2026
- 210Yang XH, Zhan XL, Xuan QX, Jin HM, Ye ZB · 2026
- 211
- 212Chen LF, Chen CJ · 2026
- 213
- 214Ponte AT, Liu A, Acquah KS, Balunas MJ · 2026
- 215
- 216Randisi F, Perletti G, Marras E, Gariboldi MB · 2025
- 217Li D, Han Y, Zhou J, Chen J, Tey HL, Tan TTY · 2025
- 218Herbal Medicines in Autism Spectrum Disorder: Therapeutic Potential, Plant Components, and Dosage GuidelinesAldekhail NM, Khojah H, Alsaadoun NH, Al-Sanea MM, Alshammari SB, Alhazeemi AH et al. · 2025
- 219Islam MR, Rauf A, Akter S, Akter H, Al-Imran MIK, Islam S et al. · 2025
- 220Liu X, Zeng T, Zhang E, Bin C, Liu Q, Wu K et al. · 2025
- 221Rovaldi E, Di Donato V, Paolino G, Bruno M, Medei A, Nisticò SP et al. · 2025
- 222
- 223
- 224Das M, Yagnik U, Raninga I, Banerjee D · 2025
- 225Kaag S, Lorentz A · 2023
- 226Cicero AFG, Fogacci F, Stoian AP, Vrablik M, Al Rasadi K, Banach M et al. · 2021
- 227Tang G, Xu Y, Zhang C, Wang N, Li H, Feng Y · 2021
- 228Hosseini A, Penson PE, Cicero AFG, Golledge J, Al-Rasadi K, Jamialahmadi T et al. · 2021
- 229Fujiki H, Watanabe T, Sueoka E, Rawangkan A, Suganuma M · 2018
- 230Fujiki H, Imai K, Nakachi K, Shimizu M, Moriwaki H, Suganuma M · 2012
- 231
- 232Rains TM, Agarwal S, Maki KC · 2011
- 233Van Poppel H, Tombal B · 2011
- 234Meltzer SM, Monk BJ, Tewari KS · 2009
Every statement on this page carries its evidence tier — proven, plausible or hypothesis — and leads to the original work. The decision in the individual case rests with the practitioner; we provide the connections.